↓ Skip to main content

Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial

Overview of attention for article published in BMC Cancer, September 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
6 X users

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial
Published in
BMC Cancer, September 2022
DOI 10.1186/s12885-022-10089-2
Pubmed ID
Authors

T. Michnevich, Y. Pan, A. Hendi, K. Oechsle, A. Stein, Y. Nestoriuc

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 19%
Student > Bachelor 5 16%
Unspecified 3 10%
Student > Doctoral Student 1 3%
Professor 1 3%
Other 1 3%
Unknown 14 45%
Readers by discipline Count As %
Medicine and Dentistry 4 13%
Psychology 4 13%
Unspecified 3 10%
Biochemistry, Genetics and Molecular Biology 1 3%
Nursing and Health Professions 1 3%
Other 4 13%
Unknown 14 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2022.
All research outputs
#6,056,105
of 23,476,369 outputs
Outputs from BMC Cancer
#1,491
of 8,483 outputs
Outputs of similar age
#112,366
of 437,669 outputs
Outputs of similar age from BMC Cancer
#21
of 234 outputs
Altmetric has tracked 23,476,369 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 8,483 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,669 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.